PROTONIX® IV Medication Guide

(pantoprazole sodium for injection)

17 PATIENT COUNSELING INFORMATION

Adverse Reactions

Advise patients to report to their healthcare provider if they experience any signs or symptoms consistent with:

•
Injection Site Reactions [see Warnings and Precautions (5.2)]
•
Potential for Exacerbation of Zinc Deficiency [see Warnings and Precautions (5.3)]
•
Acute Tubulointerstitial Nephritis [see Contraindications (4), Warnings and Precautions (5.4)]
•
Clostridium difficile-Associated Diarrhea [see Warnings and Precautions (5.5)]
•
Bone Fracture [see Warnings and Precautions (5.6)]
•
Severe Cutaneous Adverse Reactions [see Warnings and Precautions (5.7)]
•
Cutaneous and Systemic Lupus Erythematosus [see Warnings and Precautions (5.8)]
•
Hepatic Effects [see Warnings and Precautions (5.9)]
•
Hypomagnesemia and Mineral Metabolism [see Warnings and Precautions (5.10)]

Drug Interactions

Instruct patients to inform their healthcare provider of any other medications they are currently taking, including rilpivirine-containing products [Contraindications (4)] and high dose methotrexate [Warnings and Precautions (5.14)].

Pregnancy

Advise a pregnant woman of the potential risk to a fetus. Advise females of reproductive potential to inform their healthcare provider of a known or suspected pregnancy [see Use in Specific Populations (8.1)].

Find PROTONIX® IV medical information:

Find PROTONIX® IV medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PROTONIX® IV Quick Finder

Prescribing Information
Download Prescribing Information

Health Professional Information

Medication Guide

17 PATIENT COUNSELING INFORMATION

Adverse Reactions

Advise patients to report to their healthcare provider if they experience any signs or symptoms consistent with:

•
Injection Site Reactions [see Warnings and Precautions (5.2)]
•
Potential for Exacerbation of Zinc Deficiency [see Warnings and Precautions (5.3)]
•
Acute Tubulointerstitial Nephritis [see Contraindications (4), Warnings and Precautions (5.4)]
•
Clostridium difficile-Associated Diarrhea [see Warnings and Precautions (5.5)]
•
Bone Fracture [see Warnings and Precautions (5.6)]
•
Severe Cutaneous Adverse Reactions [see Warnings and Precautions (5.7)]
•
Cutaneous and Systemic Lupus Erythematosus [see Warnings and Precautions (5.8)]
•
Hepatic Effects [see Warnings and Precautions (5.9)]
•
Hypomagnesemia and Mineral Metabolism [see Warnings and Precautions (5.10)]

Drug Interactions

Instruct patients to inform their healthcare provider of any other medications they are currently taking, including rilpivirine-containing products [Contraindications (4)] and high dose methotrexate [Warnings and Precautions (5.14)].

Pregnancy

Advise a pregnant woman of the potential risk to a fetus. Advise females of reproductive potential to inform their healthcare provider of a known or suspected pregnancy [see Use in Specific Populations (8.1)].
Medication Guide

Health Professional Information

{{section_name_patient}}

{{section_body_html_patient}}

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5Pm ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.